These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28125486)

  • 1. Serious Adverse Effects of Testosterone Abuse.
    Aschenbrenner DS
    Am J Nurs; 2017 Feb; 117(2):20-21. PubMed ID: 28125486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abuse-related adverse drug reactions and abuse deterrent formulations].
    Papaseit E; Pérez-Mañá C; Torrens M; Farré M
    Med Clin (Barc); 2013 Nov; 141(10):454-8. PubMed ID: 24144061
    [No Abstract]   [Full Text] [Related]  

  • 3. USA launches plan to fight prescription drug abuse.
    Mani H
    Natl Med J India; 2011; 24(3):190. PubMed ID: 21786858
    [No Abstract]   [Full Text] [Related]  

  • 4. The Bureau of Drug Abuse Control: a review of the first two years.
    Gunn JW
    J Forensic Sci; 1968 Jul; 13(3):302-17. PubMed ID: 5757498
    [No Abstract]   [Full Text] [Related]  

  • 5. Addressing OxyContin abuse.
    FDA Consum; 2001; 35(4):3. PubMed ID: 11692884
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke.
    Seftel AD
    J Urol; 2015 Sep; 194(3):759-60. PubMed ID: 26292880
    [No Abstract]   [Full Text] [Related]  

  • 7. Primum non nocere.
    Gifford RW
    JAMA; 1977 Aug; 238(7):589-90. PubMed ID: 577959
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonprescription drugs: an overview.
    Hodes B
    Int J Health Serv; 1974; 4(1):125-30. PubMed ID: 4829892
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescription drug abuse: FDA and SAMHSA join forces.
    Meadows M
    FDA Consum; 2003; 37(2):36. PubMed ID: 12715769
    [No Abstract]   [Full Text] [Related]  

  • 10. Abuse-resistant painkillers get mixed FDA response.
    Waters H
    Nat Med; 2011 Aug; 17(8):905. PubMed ID: 21818068
    [No Abstract]   [Full Text] [Related]  

  • 11. [Legal medicine aspects of current abuse potential].
    Kauert G; Eisenmenger W
    Versicherungsmedizin; 1993 Feb; 45(1):15-7. PubMed ID: 8438535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Administration.
    Ma P; Marinovic I; Karaca-Mandic P
    JAMA Intern Med; 2015 Sep; 175(9):1565-6. PubMed ID: 26214395
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased heart attacks in men using testosterone: the UK importantly lags far behind the US in prescribing testosterone.
    Wolfe SM
    BMJ; 2014 Feb; 348():g1789. PubMed ID: 24578515
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of the Food and Drug Administration in the control of drug addiction.
    UNDERWOOD HG
    Int Rec Med Gen Pract Clin; 1956 Mar; 169(3):146-8. PubMed ID: 13294900
    [No Abstract]   [Full Text] [Related]  

  • 15. Categorization of Abuse Potential-Related Adverse Events.
    Sellers EM; Romach MK
    Clin Pharmacol Drug Dev; 2018 Aug; 7(6):569-574. PubMed ID: 29024490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States.
    Calderon SN; Klein M
    Neuropharmacology; 2014 Dec; 87():97-103. PubMed ID: 24727212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warning issued for testosterone products.
    AIDS Patient Care STDS; 2009 Jun; 23(6):491. PubMed ID: 19530320
    [No Abstract]   [Full Text] [Related]  

  • 18. Controversy over Cardiovascular Risks of Testosterone Therapy.
    Carter D
    Am J Nurs; 2015 May; 115(5):17. PubMed ID: 25906216
    [No Abstract]   [Full Text] [Related]  

  • 19. Children's exposure to testosterone gel spurs FDA to order boxed label warning.
    Voelker R
    JAMA; 2009 Jun; 301(23):2428. PubMed ID: 19531774
    [No Abstract]   [Full Text] [Related]  

  • 20. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1997 Jul; 278(1):15. PubMed ID: 9207323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.